Science Care has received investment from American Capital Equity
The private shareholders of Science Care have sold the company to American Capital Equity Management LLC for an undisclosed consideration.
Science Care is the world’s largest non-transplant human tissue (NTHT) bank. Headquartered in Phoenix, Arizona, with facilities in California, Colorado, Florida, and Pennsylvania, Science Care provides medical device companies, medical schools and hospitals with NTHT services for training and research purposes. Science Care sources tissue through voluntary whole body donation programs, prepares tissue specimens based on customer demand and specifications, and transports tissue to its domestic and international client base.
Based in Bethesda, Maryland, American Capital Equity Management is a private equity firm specializing in investments in leveraged buy-outs. The firm focuses in middle-market investments in North America. Operating as a subsidiary of American Capital, Ltd, American Capital Equity seeks to invest between US$25–150 million in companies with an EBITDA of US$5–25 million for new platforms but it does not have any minimum for add-ons. The firm seeks to invest in companies with asset-light business models with strong free cash flow conversion. It prefers to take control equity positions but with significant management ownership post close.
Oaklins' team in Los Angeles advised the seller in this transaction.
Talk to the deal team
Jeremiah Mann
Oaklins Intrepid
James Freedman
Oaklins Intrepid
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn more